Archives

by in
Entry Author Date Location
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
Gilead HIV Drug Gets FDA OK 08/10/11 San Francisco
Merck and UCSF Team Up to Find New Weapons Against Resurgent HIV 07/20/11 New York
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed 07/20/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Gilead Expands Low-Cost HIV Drug Program 07/12/11 San Francisco
Hutch, Sangamo Win $20M HIV Grant 07/11/11 Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig 06/27/11 Seattle
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
VCs Turn Up The Heat on FDA to Get Faster, More Predictable 04/25/11 National
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area 04/19/11 San Francisco
Gilead Drug Fails AIDS Prevention Trial 04/18/11 San Francisco
Tobira Pegs Nodality Vet Andrew Hindman as CEO 04/04/11 New York
Gilead Inks $100M Deal With Yale 03/31/11 San Francisco
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV 02/23/11 San Francisco
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder 02/22/11 Boston
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
State Awards Global Health Grants 01/12/11 Seattle
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News 11/12/10 Boston
EMC Acquisitions Could Include Isilon, LFB Buys GTC, Tremor Media Snaps Up ScanScout, & More Boston-Area Deals News 11/10/10 Boston
Daktari Brings In $1.8M 11/05/10 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Page 2 of 6 « previous page · next page »